臺北醫學大學癌症轉譯研究中心

Medicine & Life Sciences

1. Neoplasms 100%
2. Taiwan 90%
3. Breast Neoplasms 57%
4. Colorectal Neoplasms 52%
5. Apoptosis 49%
6. Meta-Analysis 48%
7. Neoplasm Metastasis 44%
8. Therapeutics 43%
9. Hepatocellular Carcinoma 42%
10. Genes 40%
11. Prostatic Neoplasms 40%
12. Proteins 37%
13. Glioblastoma 36%
14. Population 36%
15. Confidence Intervals 35%
16. Growth 33%
17. Cohort Studies 30%
18. Lung Neoplasms 28%
19. MicroRNAs 27%
20. Down-Regulation 27%
21. Survival 27%
22. Systematic Reviews 27%
23. Randomized Controlled Trials 26%
24. Autophagy 26%
25. Cell Line 25%
26. Neoplastic Stem Cells 24%
27. Biomarkers 24%
28. In Vitro Techniques 23%
29. Epithelial-Mesenchymal Transition 22%
30. Gene Expression 22%
31. Pharmaceutical Preparations 22%
32. Cell Movement 21%
33. ErbB Receptors 21%
34. Cell Proliferation 20%
35. Lung 20%
36. Colonic Neoplasms 20%
37. Up-Regulation 19%
38. Triple Negative Breast Neoplasms 19%
39. Temozolomide 19%
40. Mouth Neoplasms 19%
41. Non-Small Cell Lung Carcinoma 19%
42. Stroke 18%
43. Histone Deacetylase Inhibitors 18%
44. Drug Therapy 18%
45. Glioma 18%
46. Odds Ratio 18%
47. Carcinogenesis 18%
48. Adenocarcinoma of Lung 18%
49. Traumatic Brain Injury 18%
50. Catenins 18%
51. Heterografts 17%
52. Reactive Oxygen Species 17%
53. Recurrence 16%
54. Phosphorylation 16%
55. Stem Cells 16%
56. Databases 16%
57. Messenger RNA 15%
58. Cell Death 15%
59. Macrophages 15%
60. Thyroid Hormones 14%
61. Inflammation 14%
62. tetraiodothyroacetic acid 14%
63. Incidence 14%
64. Mortality 14%
65. Methylation 14%
66. Chronic Obstructive Pulmonary Disease 14%
67. Ovarian Neoplasms 14%
68. Oxidative Stress 13%
69. Androgen Receptors 13%
70. Integrins 13%
71. Squamous Cell Carcinoma 13%
72. Cell Survival 13%
73. Mesenchymal Stem Cells 13%
74. Carcinoma 13%
75. Wounds and Injuries 13%
76. Inhibitory Concentration 50 12%
77. Mitochondria 12%
78. Liver 12%
79. Radiotherapy 12%
80. Resveratrol 12%
81. DNA 12%
82. Mutation 12%
83. Fibroblasts 12%
84. Protein-Tyrosine Kinases 12%
85. Nanoparticles 12%
86. Histone Deacetylases 12%
87. Single Nucleotide Polymorphism 12%
88. Small Interfering RNA 12%
89. Phosphotransferases 11%
90. Machine Learning 11%
91. Endothelial Cells 11%
92. Cisplatin 11%
93. Propensity Score 11%
94. Phenotype 11%
95. Computational Biology 11%
96. Epigenomics 11%
97. glucose-regulated proteins 11%
98. Osteoblasts 11%
99. Ligands 11%

Chemical Compounds

1. Protein 45%
2. Drug 19%
3. Apoptotic 17%
4. Cell Death 16%
5. Biological Marker 16%
6. Marker 15%
7. Reactive Oxygen Metabolite 14%
8. Histone 14%
9. Cell Viability 11%
10. Resistance 11%
11. MicroRNA 11%
12. Antiproliferative 11%
13. Antitumor 11%
14. Temozolomide 11%
15. Genetic Polymorphism 10%
16. Antineoplastic Agent 9%
17. Oxidative Stress 9%
18. Androgen 9%
19. Growth Factor 9%
20. Air Pollution 9%
21. Antioxidant Agent 8%
22. Disorder 8%
23. Application 8%
24. Pharmacological Metabolism 8%
25. Metabolic 8%
26. Oncogenic 8%
27. Dose 7%
28. Nanoparticle 7%
29. Antiinflammatory 7%
30. Tyrosine 7%
31. Plasma 7%
32. Lipopolysaccharide 6%
33. Mutation 6%
34. Glucose 6%
35. Antigen 6%
36. Resveratrol 6%
37. Flow 5%
38. Protective 5%
39. Cisplatin 5%
40. Weight 5%
41. Estrogen 5%
42. Molecule 5%
43. Superoxide 5%
44. Metabolite 5%
45. Thyroid 5%
46. Pharmacokinetics 5%
47. Calcium(0) 5%